ETHSX vs. FBTAX
Compare and contrast key facts about Eaton Vance Worldwide Health Sciences Fund (ETHSX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX).
ETHSX is managed by Eaton Vance. It was launched on Jul 25, 1985. FBTAX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
ETHSX vs. FBTAX - Performance Comparison
Loading graphics...
ETHSX vs. FBTAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ETHSX Eaton Vance Worldwide Health Sciences Fund | -5.95% | 10.23% | 3.48% | 5.67% | -9.41% | 22.02% | 13.04% | 25.99% | 5.87% | 16.24% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 2.24% | 39.54% | 5.37% | 10.70% | -7.95% | -3.10% | 32.17% | 25.74% | -3.86% | 25.80% |
Returns By Period
In the year-to-date period, ETHSX achieves a -5.95% return, which is significantly lower than FBTAX's 2.24% return. Over the past 10 years, ETHSX has underperformed FBTAX with an annualized return of 7.59%, while FBTAX has yielded a comparatively higher 11.86% annualized return.
ETHSX
- 1D
- 2.21%
- 1M
- -6.44%
- YTD
- -5.95%
- 6M
- 1.02%
- 1Y
- 1.32%
- 3Y*
- 4.41%
- 5Y*
- 4.55%
- 10Y*
- 7.59%
FBTAX
- 1D
- 5.08%
- 1M
- -0.75%
- YTD
- 2.24%
- 6M
- 15.54%
- 1Y
- 55.40%
- 3Y*
- 20.44%
- 5Y*
- 8.92%
- 10Y*
- 11.86%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
ETHSX vs. FBTAX - Expense Ratio Comparison
ETHSX has a 1.20% expense ratio, which is higher than FBTAX's 1.00% expense ratio.
Return for Risk
ETHSX vs. FBTAX — Risk / Return Rank
ETHSX
FBTAX
ETHSX vs. FBTAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eaton Vance Worldwide Health Sciences Fund (ETHSX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETHSX | FBTAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.01 | 1.94 | -1.93 |
Sortino ratioReturn per unit of downside risk | 0.14 | 2.53 | -2.39 |
Omega ratioGain probability vs. loss probability | 1.02 | 1.33 | -0.31 |
Calmar ratioReturn relative to maximum drawdown | 0.03 | 3.16 | -3.13 |
Martin ratioReturn relative to average drawdown | 0.07 | 12.63 | -12.55 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ETHSX | FBTAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.01 | 1.94 | -1.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.38 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.48 | -0.02 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.03 | 0.31 | -0.28 |
Correlation
The correlation between ETHSX and FBTAX is 0.82, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
ETHSX vs. FBTAX - Dividend Comparison
ETHSX's dividend yield for the trailing twelve months is around 7.83%, more than FBTAX's 1.42% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETHSX Eaton Vance Worldwide Health Sciences Fund | 7.83% | 7.36% | 4.81% | 2.48% | 4.43% | 8.25% | 7.33% | 5.39% | 5.51% | 2.82% | 12.75% | 9.70% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 1.42% | 1.45% | 6.00% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% |
Drawdowns
ETHSX vs. FBTAX - Drawdown Comparison
The maximum ETHSX drawdown since its inception was -90.06%, which is greater than FBTAX's maximum drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for ETHSX and FBTAX.
Loading graphics...
Drawdown Indicators
| ETHSX | FBTAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.06% | -63.55% | -26.51% |
Max Drawdown (1Y)Largest decline over 1 year | -11.26% | -13.60% | +2.34% |
Max Drawdown (5Y)Largest decline over 5 years | -19.58% | -36.51% | +16.93% |
Max Drawdown (10Y)Largest decline over 10 years | -27.43% | -38.82% | +11.39% |
Current DrawdownCurrent decline from peak | -10.46% | -2.54% | -7.92% |
Average DrawdownAverage peak-to-trough decline | -53.13% | -21.34% | -31.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.52% | 3.71% | +0.81% |
Volatility
ETHSX vs. FBTAX - Volatility Comparison
The current volatility for Eaton Vance Worldwide Health Sciences Fund (ETHSX) is 5.09%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 9.36%. This indicates that ETHSX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ETHSX | FBTAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.09% | 9.36% | -4.27% |
Volatility (6M)Calculated over the trailing 6-month period | 10.50% | 17.00% | -6.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.73% | 26.00% | -8.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.74% | 23.32% | -8.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.25% | 24.59% | -8.34% |